IP Library Granted Patent US 8,607,785
Granted Patent B2
US 8,607,785 · App. 12/541,137 · Granted Dec 17, 2013

Systems and devices for generating nitric oxide

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,607,785
App. No.
12/541,137
Granted
Dec 17, 2013
Kind
B2
Abstract

Various systems and devices for generating nitric oxide are disclosed herein. According to one embodiment, the device includes a body having an inlet, an outlet, and a porous solid matrix positioned with the body. The porous solid matrix is coated with an aqueous solution of an antioxidant, wherein the inlet is configured to receive a gas flow and fluidly communicate the gas flow to the outlet through the solid matrix to convert nitrogen dioxide in the gas flow into nitric oxide. The porous solid matrix allows the device to be used in any orientation. Additionally, the porous solid matrix provides a rigid structure suitable to withstand vibrations and abuse without compromising device functionality.

Claims (21)

1. A device for generating nitric oxide from nitrogen dioxide, comprising:

a body including an inlet, an outlet and a diverter; and

a porous solid matrix positioned within the body and a space between the body and the porous solid matrix, wherein the porous solid matrix includes a thermoplastic resin and silica gel, wherein the porous solid matrix is coated with an antioxidant, and wherein the inlet is configured to receive a gas flow, the diverter directs the gas flow to the space between the body and the porous solid matrix, and the gas flow is fluidly communicated to the outlet through the porous solid matrix to convert nitrogen dioxide in the gas flow into nitric oxide.

2. The device of claim 1 , further comprising a humidifier in communication with the inlet of the body.

3. The device of claim 1 , wherein the antioxidant is ascorbic acid, alpha tocopherol, or gamma tocopherol.

4. The device of claim 1 , wherein the density of the silica gel is similar to the density of the thermoplastic resin.

5. The device of claim 1 , wherein the porous solid matrix comprises at least 20% silica gel.

6. The device of claim 1 , wherein the porous solid matrix comprises approximately 20% to approximately 60% silica gel.

7. A system for delivering nitric oxide to a patient, comprising:

a gas source of nitrogen dioxide, dinitrogen tetraoxide, or nitric oxide;

a first device having a body including an inlet, an outlet, a diverter, a porous solid matrix including a thermoplastic resin and silica gel and a space between the body and the porous solid matrix, wherein the porous solid matrix is coated with an antioxidant and the porous solid matrix is positioned between the inlet and the outlet, wherein the inlet is configured to receive a gas flow from the source, the diverter directs the gas flow to the space between the body and the porous solid matrix, and the gas flow is fluidly communicated to the outlet through the porous solid matrix to convert nitrogen dioxide in the gas flow into nitric oxide; and

a patient interface coupled to the outlet of the first device, the patient interface delivering nitric oxide to the patient.

8. The system of claim 7 , further comprising a humidifier positioned between the gas source and the first device.

9. The system of claim 8 , wherein the humidifier is integral with the first device.

10. The system of claim 7 , further comprising a humidifier positioned prior to the patient interface.

11. The system of claim 8 , further comprising:

a second humidifier positioned after the first device; and

a second device positioned after a second humidifier, the second device comprising an inlet, an outlet, and a porous solid matrix coated with an antioxidant, wherein the inlet is configured to receive a gas flow from the first device and fluidly communicate the gas flow to the outlet through the solid matrix to convert nitrogen dioxide in the gas flow into nitric oxide.

12. The system of claim 7 , wherein the antioxidant is ascorbic acid, alpha tocopherol, or gamma tocopherol.

13. The device of claim 1 , wherein the space is between the inlet and the porous solid matrix.

14. The system of claim 7 , wherein the space is between the inlet and the porous solid matrix.

Assignments (8)
RELEASE OF SECURITY INTEREST Recorded Mar 18, 2026
From: HORIZON TECHNOLOGY FINANCE CORPORATION
To: VERO BIOTECH INC.
Reel/Frame 075308/0198 →
SECURITY INTEREST Recorded Mar 16, 2026
From: VERO BIOTECH INC.
To: SYMBIOTIC CAPITAL AGENCY LLC, AS COLLATERAL AGENT
Reel/Frame 075117/0935 →
TERMINATION AND RELEASE OF INTELLECTUAL PROPERTY SECURITY AGREEMENT Recorded Jan 3, 2024
From: RUNWAY GROWTH FINANCE CORP (F/K/A RUNWAY GROWTH CREDIT FUND INC.)
To: VERO BIOTECH INC. (F/K/A VERO BIOTECH LLC)
Reel/Frame 066186/0611 →
SECURITY INTEREST Recorded Jan 3, 2024
From: VERO BIOTECH INC.
To: HORIZON TECHNOLOGY FINANCE CORPORATION
Reel/Frame 066187/0865 →
CHANGE OF NAME Recorded Feb 14, 2022
From: VERO BIOTECH LLC
To: VERO BIOTECH INC.
Reel/Frame 059085/0418 →
SECURITY INTEREST Recorded Dec 29, 2020
From: VERO BIOTECH LLC
To: RUNWAY GROWTH CREDIT FUND INC.
Reel/Frame 054866/0589 →
CHANGE OF NAME Recorded Jun 6, 2018
From: GENO LLC
To: VERO BIOTECH LLC
Reel/Frame 046304/0855 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 27, 2009
From: FINE, DAVID H.; JOHNSON, BRYAN; VASQUEZ, GREGORY
To: GENO LLC
Reel/Frame 023430/0515 →